<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505113</url>
  </required_header>
  <id_info>
    <org_study_id>CTPVDORNO3HSYSU</org_study_id>
    <nct_id>NCT02505113</nct_id>
  </id_info>
  <brief_title>Cavernous Transformation of Portal Veinï¼š Etiology, Diagnosis, Management and Prognosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <brief_summary>
    <textblock>
      To observe the etiology, diagnosis, management and prognosis of cavernous transformation of
      portal vein.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To observe the etiology, diagnosis, management and prognosis of cavernous transformation of
      portal vein.

      We perform Montelukast (10mg, q.d., p.o.) fot the treatment of symptomatic cavernous
      transformation of portal vein and to observe the efficacy such as the decrease of the volume
      of ascites and hydrothorax.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2010</start_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ascites Volume (mL)</measure>
    <time_frame>6 month</time_frame>
    <description>Ascites measured by CT scanning or ultrasound (If the patients had the history of ascites before)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hydrothorax Volume (mL)</measure>
    <time_frame>6 month</time_frame>
    <description>Hydrothorax measured by CT scanning or ultrasound (If the patients had the history of hydrothorax before)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Portal Vein, Cavernous Transformation Of</condition>
  <arm_group>
    <arm_group_label>CTPV without Montelukast</arm_group_label>
    <description>Patients with CTPV do not receive the treatment of Montelukast.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CTPV treated with Montelukast</arm_group_label>
    <description>Patients with CTPV treated with Montelukast (10mg, q.d., p.o.).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Montelukast</intervention_name>
    <description>Montelukast (10mg, q.d., p.o.)</description>
    <arm_group_label>CTPV treated with Montelukast</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with CTPV
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with CTPV.

        Exclusion Criteria:

          -  Patients with known severe dysfunction of heart, lung, brain, kidney and other vital
             organs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zaibo Jiang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zaibo Jiang, MD</last_name>
    <phone>+86 020 85253416</phone>
    <email>jiangzaibo@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Radiology</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaibo Jiang, MD.</last_name>
      <phone>+86 020 85253416</phone>
      <email>jiangzaibo@aliyun.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>October 28, 2015</last_update_submitted>
  <last_update_submitted_qc>October 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Zaibo Jiang</investigator_full_name>
    <investigator_title>Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University</investigator_title>
  </responsible_party>
  <keyword>Portal Vein, Cavernous Transformation Of</keyword>
  <keyword>Hypertension, Portal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Portal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Montelukast</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

